Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)

Completed · Phase 2 · Has a placebo group

Conditions studied: Polycystic Ovary Syndrome

In brief

The purpose of this study is to determine if the combination therapy of lifestyle intervention and use of Metformin together will improve ovulation induction and hyperandrogenemia in women with polycystic ovary syndrome, by gathering data from adult and adolescent females.

Key facts

Study ID

NCT00151411

Run by

Milton S. Hershey Medical Center

People needed

114

Starts

2004-10-01

Expected to finish

2008-03-01

Last updated by the study team

2018-03-21

Who can join

Age: 12 and older, up to 39. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Spontaneous intermenstrual periods of greater than or equal to 45 days or a total of 8 or less periods per year
• Elevated testosterone levels
• General good health
• Off of current medications which may confound response to study medications

You may not qualify if…

• Pregnancy
• Lactose Intolerance
• Medical Contraindications
• Elevated Prolactin, 17hydroxyprogesterone, or Follicle stimulating hormone blood tests
• Diabetes, liver, heart, kidney or uncorrected thyroid disease

Where it is running

• Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.